Weight Loss in Tomah, WI

Originally on the market to treat diabetes, Tirzepatide is now FDA approved for use in weight loss of those overweight or obese according to BMI standards since November 2023. Tirzepatide helps slow digestion to help you feel fuller longer. This in combination with lifestyle changes can help to jump start and maintain a healthy weight, decreasing risk of diabetes and cardiovascular disease. Tirzepatide (Mounjaro) outperformed Semaglutide (Ozempic) in clinical trials.

Tirzepatide is a once weekly injection into a fatty area such as the abdomen. You would see one of our nurses once weekly for follow up appointments initially to ensure you are on appropriate dosing and are tolerating the medication. Once you have met your established goal weight, our nurses will assist you in tapering off the medication.

Our nurses will review your medical history to ensure that it is safe to proceed with treatment. Some things that may exclude you from treatment are pancreatitis, thyroid conditions/tumors, pregnancy, kidney disease, liver disease, and others. Consultation is required before initiation of treatment.

Treatment begins at $500 per month. As you taper up on dosing (if this is even necessary) pricing could increase to up to $875 per month. It is in your best interest to stay on the lowest dose possible as it is not only cheaper but is tolerated with less side effects. This is meant to be utilized short term, not for life. Many clients utilize treatment for only a couple to few months, dependent on starting point and goals.